Sonorous Neurovascular Receives FDA 510(k) Clearance for BosCATH™ Neurovascular Catheter

LAKE FOREST, Calif., April 22, 2026 /PRNewswire/ -- Sonorous Neurovascular, a pioneering medical device company focused on innovative solutions for cerebral venous diseases and neurovascular interventions, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its BosCATH™, a next-generation neurovascular catheter designed to enhance access, delivery, and procedural efficiency in complex cerebral venous and arterial anatomies. Read more